[Treatment of congenital purine-pyrimidine metabolism anomalies].
D001264:Athetosis / Q000235:genetics; D002819:Chorea / Q000235:genetics; D003192:Compulsive Behavior / Q000150:complications; D006073:Gout / Q000628:therapy; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D009963:Orotic Acid / Q000652:urine; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000628:therapy*; D011687:Purines / Q000378:metabolism; D011743:Pyrimidines / Q000378:metabolism; D012652:Self Mutilation / Q000150:complications; D014166:Transferases / Q000378:metabolism; D014498:Uracil / Q000652:urine; D014527:Uric Acid / Q000097:blood
D011687:Purines; D011743:Pyrimidines; D014527:Uric Acid; D014498:Uracil; D009963:Orotic Acid; D014166:Transferases